Roshni Kulkarni: The Hidden Cost of Underdiagnosed Bleeding Disorders
Roshni Kulkarni, Professor at Michigan State University, shared a post on LinkedIn:
”So glad that the financial impact of delayed diagnosis, under treatment is being recognized.
Thanks Sanjay Ahuja.”
Sanjay Ahuja, Chief Medical Officer at Indiana Hemophilia and Thrombosis Center, shared a post on LinkedIn։
”Women with bleeding disorders remain significantly underdiagnosed and undertreated.
Delays in diagnosis can extend for years, often resulting in repeated emergency visits, chronic anemia, lost productivity and avoidable procedures.
This is not simply a clinical issue. It is a systems and cost issue
Closing this gap for women is not only the right thing to do for patients – it is a high-value, cost-effective investment for any State.”
Stay updated with Hemostasis Today.
-
Jul 12, 2026, 17:04Marc Carrier: EPCAT III Trial at ISTH 2026 Supports Aspirin Alone for VTE Prevention After Arthroplasty
-
Jul 12, 2026, 16:15Louise St. Germain Bannon: Global Collaboration Is Key to Turning Scientific Innovation Into Better Care
-
Jul 12, 2026, 16:10Marc Carrier: Major Scientific Highlight Confirms the Safety of the YEARS Algorithm at ISTH 2026
-
Jul 12, 2026, 16:01Joseph R. Shaw: Sharing New Insights into Antithrombotic Therapy and Thrombin Generation at ISTH 2026
-
Jul 12, 2026, 15:45Nathan Connell: Key Clinical Advances in Heavy Menstrual Bleeding and Postpartum Hemorrhage from ISTH 2026
-
Jul 12, 2026, 15:40Anne-Claire Duchez: Join Us at ISTH 2026 to Discover Our Latest Research and Meet the Team
-
Jul 12, 2026, 12:30Reduced-Dose DOACs in GI Malignancies: Toward Personalized Anticoagulation
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1